OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100397-100397
Closed Access | Times Cited: 14

Showing 14 citing articles:

An Occult Primary Thymic Mucosa‐Associated Lymphoid Tissue Lymphoma With Sjögren's Syndrome Revealed by CXCR4 Targeted 68Ga‐Pentixafor PET/CT
Xuehan Gao, Xingtong Peng, Rongxi Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access

Cytogenetics and genomics in CML and other myeloproliferative neoplasms
Hans Kreipe, Brigitte Schlegelberger
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 2, pp. 101552-101552
Open Access | Times Cited: 2

Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis
S. Bai, Jianxia He, Yuan-Jun Zheng, et al.
Annals of Hematology (2024) Vol. 103, Iss. 11, pp. 4649-4660
Closed Access | Times Cited: 1

Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration–Refractory Prostate Cancer
Lavinia Vija Racaru, M. Krim, V. Rivet, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 10, pp. 975-977
Closed Access | Times Cited: 1

Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
Muriel R. Battaglia, Joseph Cannova, Rafael Madero‐Marroquin, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 6, pp. 752-768
Closed Access | Times Cited: 1

New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
Yongchao Zhang, Yue Zhao, Yusi Liu, et al.
Cancer (2024)
Closed Access | Times Cited: 1

Artificial Intelligence Applications in Lymphoma Diagnosis and Management: Opportunities, Challenges, and Future Directions
Miao Shen, Zhinong Jiang
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 5329-5339
Open Access | Times Cited: 1

Mutational Analysis of Driver and Non-driver Mutations of Philadelphia Chromosome-negative Myeloproliferative Neoplasms; Diagnosis and Recent Advances in Treatment
Blessing Opeyemi Afolabi, Amani Riwaz, Jagathpriya Weerasena, et al.
World Journal of Cancer and Oncology Research (2024) Vol. 3, Iss. 1, pp. 13-32
Open Access

Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases
Federica Tiberio, Anna Rita Daniela Coda, Domiziano Dario Tosi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8860-8860
Open Access

Lymph Node Penetration From Gastric Burkitt Lymphoma in a Patient Living With HIV/AIDS
Ricardo José Razera, Ronaldo Modesto de Souza-Filho, Rosely Antunes Patzina, et al.
Cureus (2024)
Open Access

SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access

Page 1

Scroll to top